Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) Sees Significant Decrease in Short Interest

Conduit Pharmaceuticals Inc. (NASDAQ:CDTTW) saw a significant drop in short interest during the month of January. As of January 30th, there was short interest totaling 31,866 shares, a drop of 23.0% from the January 15th total of 41,372 shares. Based on an average trading volume of 36,551 shares, the days-to-cover ratio is presently 0.9 days. Based on an average trading volume of 36,551 shares, the days-to-cover ratio is presently 0.9 days.

Conduit Pharmaceuticals Trading Up 1.2%

Shares of CDTTW stock opened at $0.01 on Tuesday. The business’s 50 day simple moving average is $0.01 and its 200 day simple moving average is $0.01. Conduit Pharmaceuticals has a one year low of $0.01 and a one year high of $0.02.

About Conduit Pharmaceuticals

Conduit Pharmaceuticals Inc, a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.